Insider Trading March 16, 2026

ReposiTrak CEO Randall K. Fields Sells $32,239 in Stock Under Pre-Arranged Plan

Sale executed automatically as company reports dividend, patent-pending traceability technology and expanded grocery trade partnership

By Derek Hwang TRAK
ReposiTrak CEO Randall K. Fields Sells $32,239 in Stock Under Pre-Arranged Plan
TRAK

ReposiTrak Inc. CEO Randall K. Fields disposed of 4,000 shares on March 12, 2026, through a pre-set Rule 10b5-1 plan for a total of $32,239. The transaction occurred while the stock hovered near its 52-week low, and came amid corporate announcements including a quarterly dividend, new patent-pending traceability technology and a deeper strategic tie-up with the National Grocers Association.

Key Points

  • CEO Randall K. Fields sold 4,000 shares on March 12, 2026, under a Rule 10b5-1 plan for $8.0599 per share, totaling $32,239.
  • After the sale, Fields directly owns 3,483,955 shares and retains additional indirect holdings through several entities.
  • ReposiTrak reported a quarterly dividend, unveiled patent-pending food traceability technology, and expanded a strategic partnership with the National Grocers Association.

ReposiTrak Inc. (NASDAQ: TRAK) reported that Chief Executive Officer Randall K. Fields sold 4,000 shares of the company's common stock on March 12, 2026. The shares were sold at a per-share price of $8.0599, yielding proceeds of $32,239.

The disposition was completed in multiple executions with trade prices spanning from $7.91 to $8.17. Company filings indicate the sale was carried out automatically under a pre-arranged Rule 10b5-1 trading plan.

At the time of the transaction, the company’s share price was trading close to its 52-week low of $7.80 and the stock has declined 59% over the past year. Following the sale, Fields is recorded as directly owning 3,483,955 shares of ReposiTrak common stock.

In addition to his direct holdings, Fields holds indirect interests in company stock through several entities. Those indirect positions include 85,000 shares held by RK Fields Charitable 2022, LLC; 615,260 shares held by Riverview Financial Corp.; 30,667 shares held through his spouse; and 333,643 shares held by Fields Management, Inc.


Company fundamentals and recent corporate actions

Third-party analysis available on InvestingPro lists ReposiTrak on a Most Undervalued roster, noting a Piotroski Score of 9 and reported gross profit margins of 85%. The InvestingPro platform also provides 13 additional tips specifically for TRAK subscribers, per its offering.

Separately, ReposiTrak declared a quarterly dividend of $0.02 per share, which annualizes to $0.08 per share. The dividend is slated to be payable to shareholders of record as of December 31, 2025, with payments expected to be made around February 13, 2025.

The company has also introduced a patent-pending technology intended to automatically detect and correct errors in food traceability data. ReposiTrak says the system addresses what it characterizes as a roughly 40% average error rate in traceability records.

Finally, ReposiTrak expanded its strategic partnership with the National Grocers Association, under which ReposiTrak is designated as the strategic partner for traceability compliance management. The collaboration is focused on education, training and resources designed for independent grocers.


These developments - the insider sale, the dividend declaration, the new traceability technology and the expanded grocery trade partnership - were disclosed in company filings and third-party platform commentary and reflect ongoing corporate actions being reported publicly by ReposiTrak.

Risks

  • Share price weakness - the stock is trading near its 52-week low of $7.80 and has fallen 59% over the past year, which could affect investor sentiment and liquidity in the market - impacts equity markets and investor confidence.
  • Timing and execution details - the CEO's sale was executed under a Rule 10b5-1 plan and occurred in multiple tranches at prices between $7.91 and $8.17, which may limit visibility into timing decisions - impacts governance and market transparency considerations.
  • Operational adoption risk for new technology - the patent-pending traceability system targets a high error rate in records, but its effectiveness and adoption rate remain to be demonstrated - impacts food supply chain and retail compliance sectors.

More from Insider Trading

Sprouts CTO Disposes Small Stake as Analysts Trim Targets Mar 16, 2026 AerSale Director Adds 1,000 Shares as Stock Nears 52-Week Low Mar 16, 2026 Equillium COO Disposes $300,816 in Stock; Executes Option Exercise the Same Day Mar 16, 2026 Insider Purchase: Ten-Percent Owner Jorey Chernett Buys $257,210 of AirSculpt Technologies Stock Mar 16, 2026 BBSI CEO Buys $225K in Shares as Stock Trades Below Analyst Fair Value Mar 16, 2026